These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17137309)

  • 1. The integrated simulation and assessment of the impacts of process change in biotherapeutic antibody production.
    Chhatre S; Jones C; Francis R; O'Donovan K; Titchener-Hooker N; Newcombe A; Keshavarz-Moore E
    Biotechnol Prog; 2006; 22(6):1612-20. PubMed ID: 17137309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-support software for the industrial-scale chromatographic purification of antibodies.
    Chhatre S; Thillaivinayagalingam P; Francis R; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    Biotechnol Prog; 2007; 23(4):888-94. PubMed ID: 17630695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decision-support model for evaluating changes in biopharmaceutical manufacturing processes.
    Chhatre S; Francis R; O'Donovan K; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    Bioprocess Biosyst Eng; 2007 Jan; 30(1):1-11. PubMed ID: 17093973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Sensitivity Analysis for the determination of parameter importance in bio-manufacturing processes.
    Chhatre S; Francis R; Newcombe AR; Zhou Y; Titchener-Hooker N; King J; Keshavarz-Moore E
    Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):79-90. PubMed ID: 18205624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of crotaline F-ab antivenom (CroFab) with automated mixing methods: in vitro observations.
    Vohra R; Kelner M; Clark RF
    Clin Toxicol (Phila); 2009 Jan; 47(1):69-71. PubMed ID: 19153853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of an industrial affinity process used in the manufacturing of digoxin-specific polyclonal Fab fragments.
    Thillaivinayagalingam P; O'Donovan K; Newcombe AR; Keshavarz-Moore E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):88-96. PubMed ID: 16720112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CroFab reconstitution in various media: an in vitro solubility study.
    Vohra R; Clark R; Kelner M
    Clin Toxicol (Phila); 2008 Nov; 46(9):808-10. PubMed ID: 18821147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra scale-down approach for the prediction of full-scale recovery of ovine polycolonal immunoglobulins used in the manufacture of snake venom-specific Fab fragment.
    Neal G; Christie J; Keshavarz-Moore E; Shamlou PA
    Biotechnol Bioeng; 2003 Jan; 81(2):149-57. PubMed ID: 12451551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantification of affinity ligand leaching and specific antibody fragment concentration within chromatographic fractions using surface plasmon resonance.
    Thillaivinayagalingam P; Newcombe AR; O'Donovan K; Francis R; Keshavarz-Moore E
    Biotechnol Appl Biochem; 2007 Dec; 48(Pt 4):179-88. PubMed ID: 17516918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of whole serum and prepurified IgG digestion by pepsin for F(ab')2 manufacture.
    Boushaba R; Kumpalume P; Slater NK
    Biotechnol Prog; 2003; 19(4):1176-82. PubMed ID: 12892479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous Crotaline Fab antivenom for the treatment of rattlesnake envenomation in a porcine model.
    Offerman SR; Barry JD; Richardson WH; Tong T; Tanen D; Bush SP; Clark RF
    Clin Toxicol (Phila); 2009 Jan; 47(1):61-8. PubMed ID: 19153852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying process tradeoffs in the operation of chromatographic sequences.
    Ngiam SH; Bracewell DG; Zhou Y; Titchener-Hooker NJ
    Biotechnol Prog; 2003; 19(4):1315-22. PubMed ID: 12892496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous crotaline Fab administration in a model of rattlesnake envenomation.
    Soghoian SE; Olsen D; Al Hatali BA; Hoffman RS
    Clin Toxicol (Phila); 2009 Jul; 47(6):605-6; author reply 606. PubMed ID: 19586363
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal conditions for the papain digestion of polyclonal ovine IgG for the production of bio-therapeutic Fab fragments.
    Cresswell C; Newcombe AR; Davies S; Macpherson I; Nelson P; O'Donovan K; Francis R
    Biotechnol Appl Biochem; 2005 Oct; 42(Pt 2):163-8. PubMed ID: 15799716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating a faster method for reconstitution of Crotalidae Polyvalent Immune Fab (ovine).
    Gerring D; King TR; Branton R
    Toxicon; 2013 Jul; 69():42-9. PubMed ID: 23305624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation.
    O'Brien NF; DeMott MC; Suchard JR; Clark RF; Peterson BM
    Pediatr Emerg Care; 2009 Jul; 25(7):457-9. PubMed ID: 19606002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).
    Fazelat J; Teperman SH; Touger M
    Clin Toxicol (Phila); 2008 Nov; 46(9):823-6. PubMed ID: 18608290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioseparation in antibody manufacturing: the good, the bad and the ugly.
    Gottschalk U
    Biotechnol Prog; 2008; 24(3):496-503. PubMed ID: 18442255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality by design--thermodynamic modelling of chromatographic separation of proteins.
    Mollerup JM; Hansen TB; Kidal S; Staby A
    J Chromatogr A; 2008 Jan; 1177(2):200-6. PubMed ID: 17869261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in primary recovery: centrifugation and membrane technology.
    Roush DJ; Lu Y
    Biotechnol Prog; 2008; 24(3):488-95. PubMed ID: 18410157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.